Abstract

IKs: Another cardiovascular liability besides hERG, and use of a novel IKs blocker to screen for IKs blockade

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call